Works about KIDNEY disease risk factors


Results: 1267
    1
    2
    3
    4
    5
    6
    7
    8

    HCV and the kidney.

    Published in:
    Liver International, 2016, v. 36, p. 28, doi. 10.1111/liv.13022
    By:
    • Corouge, Marion;
    • Vallet-Pichard, Anaïs;
    • Pol, Stanislas
    Publication type:
    Article
    9
    10
    11
    12

    Your Medication Information.

    Published in:
    Brown University Psychopharmacology Update, 2024, v. 35, n. 8, p. 9, doi. 10.1002/pu.31197
    Publication type:
    Article
    13
    14
    15
    16
    17

    Low contrast media volume in pre-TAVI CT examinations.

    Published in:
    2016
    By:
    • Kok, Madeleine;
    • Turek, Jakub;
    • Mihl, Casper;
    • Reinartz, Sebastian;
    • Gohmann, Robin;
    • Nijssen, Estelle;
    • Kats, Suzanne;
    • Ommen, Vincent;
    • Kietselaer, Bas;
    • Wildberger, Joachim;
    • Das, Marco;
    • Reinartz, Sebastian D;
    • Gohmann, Robin F;
    • Nijssen, Estelle C;
    • van Ommen, Vincent G;
    • Kietselaer, Bas L J H;
    • Wildberger, Joachim E
    Publication type:
    journal article
    18

    The socioeconomic impact of kidney disease on African families: a scoping review.

    Published in:
    Discover Public Health, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12982-025-00396-x
    By:
    • Ogieuhi, Ikponmwosa Jude;
    • Aderinto, Nicholas;
    • Olatunji, Gbolahan;
    • Kokori, Emmanuel;
    • Ajekiigbe, Victor Oluwatomiwa;
    • Ayodeji, Komolafe Babajide;
    • Babalola, Adetola Emmanuel;
    • Muogbo, Ifeanyichukwu;
    • Olalekan, Alabi Badrudeen;
    • Venkatraman, Aarushi;
    • Oyewo, Oluwaseun
    Publication type:
    Article
    19

    Prophylactic Effect of Premedication with Intravenous Magnesium on Renal Dysfunction in Preoperative Cisplatin-Based Chemotherapy for Esophageal Cancer.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 319, doi. 10.1159/000501966
    By:
    • Kubo, Yuto;
    • Miyata, Hiroshi;
    • Sugimura, Keijiro;
    • Shinno, Naoki;
    • Ushigome, Hajime;
    • Yanagimoto, Yoshitomo;
    • Takahashi, Yusuke;
    • Yamamoto, Kazuyoshi;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Takahashi, Hidenori;
    • Yasui, Masayoshi;
    • Omori, Takeshi;
    • Ohue, Masayuki;
    • Yano, Masahiko
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1369, doi. 10.1111/dom.13245
    By:
    • Heerspink, Hiddo J. L.;
    • de Zeeuw, Dick;
    • Perkovic, Vlado;
    • Tobe, Sheldon;
    • Parving, Hans‐Henrik;
    • Andress, Dennis L.;
    • Brennan, John J.;
    • Dey, Jyotirmoy;
    • Wigderson, Melissa;
    • Bakris, George;
    • Correa‐Rotter, Ricardo;
    • Hou, Fan Fan;
    • Kitzman, Dalane W.;
    • Kohan, Donald;
    • Makino, Hirofumi;
    • McMurray, John
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50